Literature DB >> 17222411

Functional glycosylation of human podoplanin: glycan structure of platelet aggregation-inducing factor.

Mika Kato Kaneko1, Yukinari Kato, Akihiko Kameyama, Hiromi Ito, Atsushi Kuno, Jun Hirabayashi, Tomomi Kubota, Koh Amano, Yasunori Chiba, Yasushi Hasegawa, Isoji Sasagawa, Kazuhiko Mishima, Hisashi Narimatsu.   

Abstract

Podoplanin (Aggrus) is a mucin-type sialoglycoprotein that plays a key role in tumor cell-induced platelet aggregation. Podoplanin possesses a platelet aggregation-stimulating (PLAG) domain, and Thr52 in the PLAG domain of human podoplanin is important for its activity. Endogenous or recombinant human podoplanin were purified, and total glycosylation profiles were surveyed by lectin microarray. Analyses of glycopeptides produced by Edman degradation and mass spectrometry revealed that the disialyl-corel (NeuAc alpha2-3Gal beta l-3(NeuAc alpha2-6)GalNAc alpha l-O-Thr) structure was primarily attached to a glycosylation site at residue Thr52. Sialic acid-deficient podoplanin recovered its activity after additional sialylation. These results indicated that the sialylated Corel at Thr52 is critical for podoplanin-induced platelet aggregation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17222411     DOI: 10.1016/j.febslet.2006.12.044

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  35 in total

1.  Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas.

Authors:  Yukinari Kato; Ganesan Vaidyanathan; Mika Kato Kaneko; Kazuhiko Mishima; Nidhi Srivastava; Vidyalakshmi Chandramohan; Charles Pegram; Stephen T Keir; Chien-Tsun Kuan; Darell D Bigner; Michael R Zalutsky
Journal:  Nucl Med Biol       Date:  2010-10       Impact factor: 2.408

Review 2.  Mucin-type O-glycosylation is critical for vascular integrity.

Authors:  Brett H Herzog; Jianxin Fu; Lijun Xia
Journal:  Glycobiology       Date:  2014-06-19       Impact factor: 4.313

3.  Podoplanin requires sialylated O-glycans for stable expression on lymphatic endothelial cells and for interaction with platelets.

Authors:  Yanfang Pan; Tadayuki Yago; Jianxin Fu; Brett Herzog; J Michael McDaniel; Padmaja Mehta-D'Souza; Xiaofeng Cai; Changgeng Ruan; Rodger P McEver; Christopher West; Kesheng Dai; Hong Chen; Lijun Xia
Journal:  Blood       Date:  2014-10-21       Impact factor: 22.113

4.  Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via PEAR1 and GPIbα.

Authors:  Caroline Kardeby; Knut Fälker; Elizabeth J Haining; Maarten Criel; Madelene Lindkvist; Ruben Barroso; Peter Påhlsson; Liza U Ljungberg; Mattias Tengdelius; G Ed Rainger; Stephanie Watson; Johannes A Eble; Marc F Hoylaerts; Jonas Emsley; Peter Konradsson; Steve P Watson; Yi Sun; Magnus Grenegård
Journal:  Blood Adv       Date:  2019-02-12

5.  Polypeptide N-Acetylgalactosaminyltransferase 13 Contributes to Neurogenesis via Stabilizing the Mucin-type O-Glycoprotein Podoplanin.

Authors:  Yingjiao Xu; Wenjie Pang; Jishun Lu; Aidong Shan; Yan Zhang
Journal:  J Biol Chem       Date:  2016-09-14       Impact factor: 5.157

Review 6.  Functional significance of the platelet immune receptors GPVI and CLEC-2.

Authors:  Julie Rayes; Steve P Watson; Bernhard Nieswandt
Journal:  J Clin Invest       Date:  2019-01-02       Impact factor: 14.808

7.  Engineering of mucin-type human glycoproteins in yeast cells.

Authors:  Koh Amano; Yasunori Chiba; Yoshiko Kasahara; Yukinari Kato; Mika Kato Kaneko; Atsushi Kuno; Hiromi Ito; Kazuo Kobayashi; Jun Hirabayashi; Yoshifumi Jigami; Hisashi Narimatsu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-22       Impact factor: 11.205

Review 8.  Podoplanin--a novel marker in oral carcinogenesis.

Authors:  Niharika Swain; Shwetha V Kumar; Samapika Routray; Jigna Pathak; Shilpa Patel
Journal:  Tumour Biol       Date:  2014-06-27

Review 9.  Podoplanin - a small glycoprotein with many faces.

Authors:  Maciej Ugorski; Piotr Dziegiel; Jaroslaw Suchanski
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

10.  Galectin-8 interacts with podoplanin and modulates lymphatic endothelial cell functions.

Authors:  Leah N Cueni; Michael Detmar
Journal:  Exp Cell Res       Date:  2009-03-04       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.